NBIX Neurocrine Biosciences, Inc.

NASDAQ
$149.50

Neurocrine Biosciences, Inc. (NBIX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with NBIX's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 6 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
15
40 transactions
Purchases
$0
0 shares
Sales
$77.9M
501,949 shares
Net activity
-$77.9M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $77.8M 39 transactions · 501,649 shares
Discretionary sales $42.6K 1 transaction · 300 shares

Largest single sale: $37.8M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
ABERNETHY MATT Chief Financial Officer Sell 10b5-1 2,311 $157.20 $363.3K 42,808 −5.1% of holding
Boyer David W. Chief Corp. Affairs Officer Sell 10b5-1 826 $157.45 $130.1K 8,722 −8.7% of holding
BENEVICH ERIC Chief Commercial Officer Sell 10b5-1 2,154 $154.61 $333.0K 64,408 −3.2% of holding
Norwalk Leslie V Director Sell 10b5-1 1,250 $182.01 $227.5K 1,588 −44% of holding
Delaet Ingrid Chief Regulatory Officer Sell 10b5-1 4,367 $181.02 $790.5K 16,225 −21.2% of holding
Lippoldt Darin Chief Legal Officer Sell 10b5-1 10,000 $179.60 $1.8M 54,729 −15.4% of holding
Delaet Ingrid Chief Regulatory Officer Sell 10b5-1 8,433 $178.72 $1.5M 16,225 −34.2% of holding
Delaet Ingrid Chief Regulatory Officer Sell 10b5-1 2,737 $178.54 $488.7K 16,225 −14.4% of holding
Delaet Ingrid Chief Regulatory Officer Sell 10b5-1 3,401 $178.57 $607.3K 16,225 −17.3% of holding
Lippoldt Darin 2 fills Chief Legal Officer Sell 10b5-1 9,800 $170.16 $1.7M 54,729 −15.2% of holding
Lippoldt Darin Chief Legal Officer Sell 10b5-1 200 $169.56 $33.9K 54,729 −0.4% of holding
SHERWIN STEPHEN A 5 fills Director Sell 10b5-1 25,000 $165.32 $4.1M 32,977 −43.1% of holding
Norwalk Leslie V Director Sell 10b5-1 1,250 $168.06 $210.1K 2,838 −30.6% of holding
Cooke Julie 5 fills Chief Human Resources Officer Sell 10b5-1 36,937 $156.22 $5.8M 45,097 −45% of holding
Onyia Jude Chief Scientific Officer Sell 10b5-1 11,000 $160.25 $1.8M 25,846 −29.9% of holding
Delaet Ingrid Chief Regulatory Officer Sell 10b5-1 2,261 $156.71 $354.3K 16,225 −12.2% of holding
Onyia Jude Chief Scientific Officer Sell 10b5-1 11,000 $155.53 $1.7M 25,846 −29.9% of holding
Boyer David W. Chief Corp. Affairs Officer Sell 10b5-1 3,888 $156.64 $609.0K 7,799 −33.3% of holding
GORMAN KEVIN CHARLES Director Sell 10b5-1 245,088 $154.33 $37.8M 511,293 −32.4% of holding
POPS RICHARD F Director Sell 10b5-1 15,000 $157.65 $2.4M 34,480 −30.3% of holding
Norwalk Leslie V Director Sell 10b5-1 3,810 $155.01 $590.6K 2,429 −61.1% of holding
Gano Kyle 2 fills Chief Executive Officer Sell 10b5-1 36,400 $132.70 $4.8M 140,407 −20.6% of holding
Norwalk Leslie V Director Sell 10b5-1 1,190 $155.09 $184.6K 6,239 −16% of holding
Norwalk Leslie V Director Sell 10b5-1 5,000 $152.23 $761.1K 7,429 −40.2% of holding
Lippoldt Darin Chief Legal Officer Sell 10b5-1 4,376 $159.65 $698.6K 43,405 −9.2% of holding
LYONS GARY A Director Sell 10b5-1 15,000 $152.61 $2.3M 120,482 −11.1% of holding
BENEVICH ERIC Chief Commercial Officer Sell 10b5-1 5,970 $151.74 $905.9K 44,893 −11.7% of holding
MORROW GEORGE J Director Sell 10b5-1 15,000 $143.37 $2.2M 7,068 −68% of holding
RASTETTER WILLIAM H Director Sell 10b5-1 18,000 $151.82 $2.7M 40,360 −30.8% of holding
Gano Kyle Chief Executive Officer Sell 300 $141.97 $42.6K 140,407 −0.2% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.